ProSciento, Inc. is a clinical research site located in Chula Vista, California, United States 91911.
Crixeo Health Trust Score: 80/100 (GOOD). This profile has not yet been claimed by the site owner.
ProSciento, Inc. has participated in 15 clinical trials with 2 currently active.
Therapeutic areas: Type 2 Diabetes, Hypoglycemia, Diabetes Mellitus, Type 1.
Sponsors: Glyscend, Inc., Zealand Pharma, Xeris Pharmaceuticals.
Trust Score: 80/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
ProSciento, Inc. has a Crixeo Trust Score of 80/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
ProSciento, Inc. has 15 clinical trials on record, with 2 currently active. Their work covers Type 2 Diabetes, Hypoglycemia, Diabetes Mellitus, Type 1.
Yes — ProSciento, Inc. holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.